전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
asas
asas
마지막 업데이트: 2017-04-26
사용 빈도: 2
품질:
asas 20
acr 20
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
asas 50 er
asas 50 me
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
asas 5/6
7.9 (16.1)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
asas 70 t la
asas 70
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
asas 20-respons,
asas 20 response, %
마지막 업데이트: 2017-04-26
사용 빈도: 2
품질:
asas partiële remissie
asas partial remission
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
week 2 week 12 week 24 asas 50
week 2 week 12 week 24
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
2 weken 3 maanden 6 maanden asas 50
2 weeks 3 months 6 months asas 50
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
2 weken 3 maanden 6 maanden asas 70:
3 months 6 months
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
er werd ook een significante verbetering waargenomen voor de asas gedeeltelijke remissie en voor basdai 50.
significant improvement was also observed for the asas partial remission and basdai 50.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
het primaire eindpunt was het percentage patiënten dat in week 16 een asas 20 respons had bereikt.
the primary endpoint was the proportion of patients achieving asas 20 response at week 16.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
(vroeger adres), c) asas village, abu ghurayb, irak
(previous address), (c) asas village, abu ghurayb, iraq
마지막 업데이트: 2014-11-11
사용 빈도: 1
품질:
asas 50 en asas 70 responsen gebruikten dezelfde criteria met respectievelijk een 50% verbetering en een 70% verbetering.
asas 50 and 70 responses used the same criteria with a 50% improvement or a 70% improvement, respectively.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
onder de patiënten die in de studie bleven en behandeld werden met simponi, was het percentage patiënten met een asas 20 en asas 40 respons vergelijkbaar van week 24 tot einde week 256.
among patients remaining in the study and treated with simponi, the proportion of patients with an asas 20 and asas 40 response were similar from week 24 through week 256.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
personen (n=215, 54,7%) die asas 20 niet binnen 12, 16 of 20 weken bereikten, kregen kortdurend open-label adalimumab 40 mg eenmaal per twee weken subcutaan en werden verder behandeld als non-responders in de dubbelblinde statistische analyses.
subjects (n = 215, 54.7%) who failed to achieve asas 20 at weeks 12, or 16 or 20 received early escape open-label adalimumab 40 mg every other week subcutaneously and were subsequently treated as non-responders in the double-blind statistical analyses.
마지막 업데이트: 2017-04-26
사용 빈도: 6
품질: